Search all trials

Find therapies in clinical trials near you – page 86

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Portal hypertension

Not recruiting

Registered drugNo placebo

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Bi 685509

Contact Research Centre

Hyperoxaluria

Not recruiting

Registered drugNo placebo

Study on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Lumasiran

Contact Research Centre

Parkinson's disease

Not recruiting

Investigational

Study on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:5,7-Dimethyl-N-((1R,4R)-4-(Pentyloxy)Cyclohexyl)Pyrazolo[1,5-A]Pyrimidine-3-Carboxamide

Contact Research Centre

COVID-19+2

Not recruiting

Registered drugNo placebo

Study on Everolimus and Mycophenolate Mofetil for Improving COVID-19 Vaccine Response in Kidney Transplant Patients

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Not recruiting

Registered drugNo placebo

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Bladder cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Aortic stenosis

Not recruiting

Registered drug

Study on Protamine Sulfate and Sodium Chloride to Reduce Bleeding in Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Protamine Sulfate

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drugNo placebo

Study on Reducing Dupilumab Dose for Patients with Controlled Atopic Eczema

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Dupilumab

Contact Research Centre

Colorectal cancer+5

Not recruiting

Registered drugNo placebo

Study of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Prinzmetal angina

Not recruiting

Registered drug

Study on the Effects of Vericiguat on Patients with Vasospastic Angina

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Insulin Aspart

Contact Research Centre

Non-small cell lung cancer

Not recruiting

InvestigationalNo placebo

Study of TAS3351 for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Tas3351

Contact Research Centre

Find therapies in clinical trials near you – page 86

1 084 trials match your criteria

Neoplasm malignant

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

Portal hypertension

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Hyperoxaluria

Study on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1

Parkinson's disease

Study on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant

COVID-19+2

Study on Everolimus and Mycophenolate Mofetil for Improving COVID-19 Vaccine Response in Kidney Transplant Patients

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Bladder cancer

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Aortic stenosis

Study on Protamine Sulfate and Sodium Chloride to Reduce Bleeding in Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Dermatitis atopic

Study on Reducing Dupilumab Dose for Patients with Controlled Atopic Eczema

Colorectal cancer+5

Study of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer

Prinzmetal angina

Study on the Effects of Vericiguat on Patients with Vasospastic Angina

Non-small cell lung cancer

Study of TAS3351 for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.